Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,027,201,493.43
- March 10, 2025
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 15, 2018 | EVP | 138 | $155.78 | Sell | $21,497.64 | |
| May 15, 2018 | SVP | 201 | $155.78 | Sell | $31,311.78 | |
| May 11, 2018 | COO | 4,096 | $155.00 | Sell | $634,880.00 | |
| May 3, 2018 | EVP | 2,330 | $149.50 | Sell | $348,335.00 | |
| April 26, 2018 | EVP | 40,764 | $159.29 | Sell | $6,493,297.56 | |
| April 26, 2018 | COO | 85,093 | $158.32 | Sell | $13,471,923.76 | |
| April 18, 2018 | SVP | 859 | $166.05 | Sell | $142,636.95 | |
| April 16, 2018 | EVP | 2,125 | $163.01 | Sell | $346,396.25 | |
| April 2, 2018 | SVP | 3,438 | $161.21 | Sell | $554,239.98 | |
| March 9, 2018 | EVP | 13,750 | $175.00 | Sell | $2,406,250.00 | |
| March 2, 2018 | Director | 10,000 | $170.00 | Sell | $1,700,000.00 | |
| Feb. 26, 2018 | EVP | 6,459 | $169.00 | Sell | $1,091,571.00 | |
| Feb. 20, 2018 | SVP | 3,437 | $158.49 | Sell | $544,730.13 | |
| Feb. 12, 2018 | SVP | 4,213 | $153.41 | Sell | $646,316.33 | |
| Feb. 12, 2018 | EVP | 12,136 | $153.41 | Sell | $1,861,783.76 | |
| Feb. 12, 2018 | CMO | 5,122 | $150.82 | Sell | $772,500.04 | |
| Feb. 12, 2018 | CEO | 23,905 | $150.83 | Sell | $3,605,591.15 | |
| Feb. 5, 2018 | SVP | 2,098 | $163.08 | Sell | $342,141.84 | |
| Feb. 5, 2018 | EVP | 4,520 | $163.01 | Sell | $736,805.20 | |
| Feb. 5, 2018 | CMO | 3,594 | $161.46 | Sell | $580,287.24 | |
| Feb. 2, 2018 | SVP | 9,883 | $173.50 | Sell | $1,714,700.50 | |
| Feb. 2, 2018 | EVP | 2,156 | $169.42 | Sell | $365,269.52 | |
| Feb. 2, 2018 | CMO | 3,696 | $166.79 | Sell | $616,455.84 | |
| Jan. 29, 2018 | EVP | 15,085 | $170.00 | Sell | $2,564,450.00 | |
| Jan. 24, 2018 | EVP | 8,969 | $169.00 | Sell | $1,515,761.00 | |
| Jan. 23, 2018 | SVP | 5,435 | $164.03 | Sell | $891,503.05 | |
| Jan. 23, 2018 | Director | 20,000 | $162.50 | Sell | $3,250,000.00 | |
| Jan. 22, 2018 | EVP | 46,172 | $158.65 | Sell | $7,325,187.80 | |
| Jan. 19, 2018 | EVP | 32,422 | $158.08 | Sell | $5,125,269.76 | |
| Jan. 16, 2018 | CEO | 99,563 | $156.99 | Sell | $15,630,395.37 | |
| Jan. 16, 2018 | CMO | 1,719 | $157.28 | Sell | $270,364.32 | |
| Jan. 16, 2018 | EVP | 2,125 | $158.28 | Sell | $336,345.00 | |
| Jan. 11, 2018 | EVP | 4,250 | $159.00 | Sell | $675,750.00 | |
| Jan. 5, 2018 | Director | 10,753 | $156.00 | Sell | $1,677,468.00 | |
| Jan. 2, 2018 | CFO | 777 | $149.95 | Sell | $116,511.15 | |
| Jan. 2, 2018 | CMO | 3,438 | $151.80 | Sell | $521,888.40 | |
| Dec. 27, 2017 | SVP | 1,289 | $152.31 | Sell | $196,327.59 | |
| Dec. 11, 2017 | CEO | 125,000 | $141.35 | Sell | $17,668,750.00 | |
| Nov. 15, 2017 | EVP | 221 | $147.29 | Sell | $32,551.09 | |
| Nov. 6, 2017 | COO | 6,405 | $150.00 | Sell | $960,750.00 | |
| Nov. 6, 2017 | EVP | 4,250 | $148.17 | Sell | $629,722.50 | |
| Nov. 3, 2017 | COO | 2,155 | $150.00 | Sell | $323,250.00 | |
| Nov. 3, 2017 | CMO | 5,390 | $144.71 | Sell | $779,986.90 | |
| Nov. 3, 2017 | EVP | 2,330 | $149.50 | Sell | $348,335.00 | |
| Nov. 3, 2017 | Director | 7,073 | $143.05 | Sell | $1,011,792.65 | |
| Oct. 31, 2017 | EVP | 40,000 | $145.05 | Sell | $5,802,000.00 | |
| Oct. 31, 2017 | COO | 75,000 | $145.06 | Sell | $10,879,500.00 | |
| Oct. 31, 2017 | CMO | 60,000 | $145.05 | Sell | $8,703,000.00 | |
| Oct. 27, 2017 | EVP | 6,290 | $143.97 | Sell | $905,571.30 | |
| Oct. 16, 2017 | COO | 2,125 | $155.61 | Sell | $330,671.25 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ourania Tatsis, Ian F Smith, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Charles F Wagner Jr, Carmen Bozic, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Kenneth Horton, Sangeeta N. Bhatia, Ian F. Smith, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, William D Young, Jonathan Biller, Edward Morrow Atkinson III, and Lloyd Carney
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 10, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.